Failure of repeated electroconvulsive shock treatment on 5-HT 4-receptor-mediated depolarization due to protein kinase A system in young rat hippocampal CA1 neurons

Journal of Pharmacological Sciences

Volumn 95, Issue 3, 2004, Pages 329-334

  Ishihara, Kumatoshi ^a,c   Sasa, Masashi ^b,d  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^d Nagisa Hospital   (Japan)

Author keywords

5 HT4 receptor; Depolarization; Electroconvulsive shock; Hippocampal CA1 region; Serotonin (5 HT)

Indexed keywords

1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 3 (1 BUTYL 4 PIPERIDINYL) 1 PROPANONE; 1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 3 [1 [2 (METHANESULFONAMIDO)ETHYL] 4 PIPERIDINYL] 1 PROPANONE; 1 METHYL 3 INDAZOLECARBOXYLIC ACID N TROPANYLAMIDE; ADENYLATE CYCLASE ACTIVATOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FORSKOLIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RS 39604; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 AGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC SHOCK; ELECTROCONVULSIVE THERAPY; ENZYME ACTIVATION; HIPPOCAMPUS; INHIBITION KINETICS; MALE; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; NERVE CELL; NONHUMAN; PROTEIN FUNCTION; RAT; RECEPTOR BINDING; SECOND MESSENGER; SEROTONIN RELEASE;

EID: 3843139448     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FP0030382     Document Type: Article

References (27)

1. Murphy DL. Neuropsychiatric disorder and the multiple human brain serotonin receptor subtypes and subsystems. Neuropsychopharmacology. 1990;3:457-471.
2. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 1994;46:157-203.
3. 1A receptor function following repeated electroconvulsive shock in young rat hippocampal neurons in vitro. Int J Neuropsychopharmacol. 1999;2:101-104.
4. 4 receptor-mediated depolarization in hippocampal CA1 neurons. Jpn J Pharmacol. 2000;82 Suppl I:180P.
5. 3 receptor functions in the hippocampal CA1 region of rats following repeated electroconvulsive shock treatments. Neurosci Lett. 2001;307: 37-40.
6. Andrade R, Nicoll RA. Pharmacologically distinct actions of serotonin on single pyramidal neurons of the rat hippocampus recorded in vitro. J Physiol (Lond). 1987;394:99-124.
7. Ropert N, Guy N. Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro. J Physiol (Lond). 1991;441:121-136.
8. McMahon LL, Kauer JA. Hippocampal interneurons are excited via serotonin-gated ion channels. J Neurophysiol. 1997;78: 2493-2502.
9. 4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. J Pharmacol Exp Ther. 1991;257:930-937.
10. Torres GE, Chaput Y, Andrade R. Cyclic AMP and protein kinase A mediate 5-hydroxytryptamine type 4 receptor regulation of calcium-activated potassium current in adult hippocampal neurons. Mol Pharmacol. 1995;47:191-197.
11. Avery D, Winokur G. The efficacy of electroconvulsive therapy and antidepressants in depression. Biol Psychiatry. 1977;12: 507-523.
12. Strober M, Rao U, DeAntonio M, Liston E, State M, Amaya-Jackson L, et al. Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy. Biol Psychiatry. 1998;43:335-338.
13. 4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo. Br J Pharmacol. 1995;115:1387-1392.
14. 4 receptor antagonist. Br J Pharmacol. 1995;115:1087-1095.
15. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem. 1990;265: 5267-5272.
16. Seamon KB, Padgett W, Daly JW. Forskolin: unique diterpene activator of adenylate cyclase in membrane and in intact cells. Proc Natl Acad Sci USA. 1981;78:3363-3367.
17. 4 receptor-mediated responses in adult hippocampal neurons. J Pharmacol Exp Ther. 1994;271:255-261.
18. 4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives. Mol Pharmacol. 1990;37:408-411.
19. Dumuis A, Bouhelal R, Sebben M, Bockaert J. A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930. Eur J Pharmacol. 1988;146:187-188.
20. Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol. 1988;34:880-887.
21. Shenker A, Maayani S, Weinstein H, Green JP. Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes. Mol Pharmacol. 1987;31:357-367.
22. 4 receptor-induced depolarization in rat hippocampal neurons is mediated by cAMP but is independent of Ih. Neurosci Lett. 2002;324:1-4.
23. 7 receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization. J Pharmacol Exp Ther. 2001;297:395-402.
24. 4 receptor activation. Naunyn Schmidebergs Arch Pharmacol. 2001;363:491-498.
25. Gasparini S, DiFrancesco D. Action of serotonin on the hyperpolarization-activated cation current (Ih) in rat CA1 hippocampal neurons. Eur J Neurosci. 1999;11:3093-3100.
26. 4 receptor activation, a possible mediation via an alteration in the postreceptor transduction mechanism involving adenylate cyclase. Pol J Pharmacol. 1997;49:345-350.
27. 4 receptor activation in the rat hippocampus. Naunyn Schimiedebergs Arch Pharmacol. 1997;355:14-19.